Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10


BAP1 expression is prognostic in breast and uveal melanoma but not colon cancer and is highly positively correlated with RBM15B and USP19.

Shahriyari L, Abdel-Rahman M, Cebulla C.

PLoS One. 2019 Feb 4;14(2):e0211507. doi: 10.1371/journal.pone.0211507. eCollection 2019.


Standardized method for the measurement of Grabb's line and clival-canal angle.

Martin JE, Bookland M, Moote D, Cebulla C.

J Neurosurg Pediatr. 2017 Oct;20(4):352-356. doi: 10.3171/2017.5.PEDS17181. Epub 2017 Aug 11.


BAP1 Tumor Predisposition Syndrome.

Pilarski R, Rai K, Cebulla C, Abdel-Rahman M.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019.
2016 Oct 13.


Diagnostic challenges in retinitis pigmentosa: genotypic multiplicity and phenotypic variability.

Chang S, Vaccarella L, Olatunji S, Cebulla C, Christoforidis J.

Curr Genomics. 2011 Jun;12(4):267-75. doi: 10.2174/138920211795860116.


Novel retinoblastoma treatment avoids chemotherapy: the effect of optimally timed combination therapy with angiogenic and glycolytic inhibitors on LH(BETA)T(AG) retinoblastoma tumors.

Houston SK, Piña Y, Murray TG, Boutrid H, Cebulla C, Schefler AC, Shi W, Celdran M, Feuer W, Merchan J, Lampidis TJ.

Clin Ophthalmol. 2011 Jan 27;5:129-37. doi: 10.2147/OPTH.S15179.


Retinal tumor imaging and volume quantification in mouse model using spectral-domain optical coherence tomography.

Ruggeri M, Tsechpenakis G, Jiao S, Jockovich ME, Cebulla C, Hernandez E, Murray TG, Puliafito CA.

Opt Express. 2009 Mar 2;17(5):4074-83.


Heterogeneous tumor vasculature in retinoblastoma: implications for vessel targeting therapy.

Jockovich ME, Piña Y, Alegret A, Cebulla C, Feuer W, Murray TG.

Retina. 2008 Mar;28(3 Suppl):S81-6. doi: 10.1097/IAE.0b013e318150d6f0. Erratum in: Retina. 2009 Jan;29(1):127.


Mechanism of retinoblastoma tumor cell death after focal chemotherapy, radiation, and vascular targeting therapy in a mouse model.

Jockovich ME, Suarez F, Alegret A, Piña Y, Hayden B, Cebulla C, Feuer W, Murray TG.

Invest Ophthalmol Vis Sci. 2007 Dec;48(12):5371-6.


Human cytomegalovirus protein pp71 disrupts major histocompatibility complex class I cell surface expression.

Trgovcich J, Cebulla C, Zimmerman P, Sedmak DD.

J Virol. 2006 Jan;80(2):951-63.

Supplemental Content

Loading ...
Support Center